Last reviewed · How we verify
Ventricular Fibrillation
Approved treatments
- Bretylium Tosylate · Pfizer
- Cordarone · Pfizer
Amiodarone, a class III antiarrhythmic, blocks sodium, potassium, and calcium channels, prolongs cardiac action potentials, and has vasodilatory effects. - Onoact · Aop Hlth Us
Onoact works by blocking the beta-1 adrenergic receptor, which helps to slow down abnormal heart rhythms.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Ventricular Fibrillation patent landscape — cliff calendar, originator estates, attackable patents
- Ventricular Fibrillation treatment landscape brief
- Ventricular Fibrillation treatment updates RSS
Frequently asked questions about Ventricular Fibrillation
What drugs treat Ventricular Fibrillation?
Tracked treatments include Bretylium Tosylate, Cordarone, Onoact.
What is the treatment for Ventricular Fibrillation?
Standard treatment for Ventricular Fibrillation includes Bretylium Tosylate, Cordarone, Onoact. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Ventricular Fibrillation patent cliff · Ventricular Fibrillation CI report
- Treatment: Bretylium Tosylate · Pfizer
- Treatment: Cordarone · Pfizer
- Treatment: Onoact · Aop Hlth Us
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing